| Recent advances in BLV research PY Barez, A De Brogniez, A Carpentier, H Gazon, N Gillet, G Gutiérrez, ... Viruses 7 (11), 6080-6088, 2015 | 117 | 2015 |
| Grasshoppers as a food source? A review A Paul, M Frederich, R Uyttenbroeck, S Hatt, P Malik, S Lebecque, ... Biotechnologie, Agronomie, Société et Environnement 20 (AgricultureIsLife), 2016 | 108 | 2016 |
| Bovine leukemia virus small noncoding RNAs are functional elements that regulate replication and contribute to oncogenesis in vivo NA Gillet, M Hamaidia, A De Brogniez, G Gutierrez, N Renotte, M Reichert, ... PLoS Pathogens 12 (4), e1005588, 2016 | 73 | 2016 |
| Modes of human T cell leukemia virus type 1 transmission, replication and persistence A Carpentier, PY Barez, M Hamaidia, H Gazon, A De Brogniez, S Perike, ... Viruses 7 (7), 3603-3624, 2015 | 59 | 2015 |
| Inhibition of EZH2 methyltransferase decreases immunoediting of mesothelioma cells by autologous macrophages through a PD-1–dependent mechanism M Hamaidia, H Gazon, C Hoyos, GB Hoffmann, R Louis, B Duysinx, ... JCI insight 4 (18), 2019 | 44 | 2019 |
| BLV: lessons on vaccine development A Abdala, I Alvarez, H Brossel, L Calvinho, H Carignano, L Franco, ... Retrovirology 16, 1-6, 2019 | 33 | 2019 |
| Cis-drivers and trans-drivers of bovine leukemia virus oncogenesis R Safari, M Hamaidia, A De Brogniez, N Gillet, L Willems Current Opinion in Virology 26, 15-19, 2017 | 22 | 2017 |
| Sphingolipids: Promising lipid-class molecules with potential applications for industry. A review K Miazek, S Lebecque, M Hamaidia, A Paul, S Danthine, L Willems, ... Biotechnologie, Agronomie, Société et Environnement 20 (S1), 2016 | 12 | 2016 |
| Improvement of malignant pleural mesothelioma immunotherapy by epigenetic modulators M Hamaidia, B Staumont, B Duysinx, R Louis, L Willems Current Topics in Medicinal Chemistry 16 (7), 777-787, 2016 | 11 | 2016 |
| How does htlv-1 undergo oncogene-dependent replication despite a strong immune response? H Gazon, P Chauhan, M Hamaidia, C Hoyos, L Li, R Safari, L Willems Frontiers in Microbiology 8, 2684, 2018 | 10 | 2018 |
| From Valeriana officinalis to cancer therapy: the success of a bio-sourced compound M Hamaidia, PY Barez, A Carpentier, S Lebecque, K Miazek, A Paul, ... BASE, 2016 | 10 | 2016 |
| Toll-like receptor 4 selective inhibition in medullar microenvironment alters multiple myeloma cell growth L Lemaitre, M Hamaidia, JG Descamps, L Do Souto Ferreira, MV Joubert, ... Blood Advances 6 (2), 672-678, 2022 | 9 | 2022 |
| Recent advances in BLV research. Viruses 7: 6080–6088 PY Barez, A De Brogniez, A Carpentier, H Gazon, N Gillet, G Gutiérrez, ... | 7 | 2015 |
| Activation of DNA damage tolerance pathways may improve immunotherapy of mesothelioma H Brossel, A Fontaine, C Hoyos, M Jamakhani, M Willems, M Hamaidia, ... Cancers 13 (13), 3211, 2021 | 6 | 2021 |
| The bovine leukemia virus microRNAs permit escape from innate immune response and contribute to viral replication in the natural host NA Gillet, M Hamaidia, A De Brogniez, G Gutiérrez, N Renotte, M Reichert, ... Retrovirology 12, 1-1, 2015 | 6 | 2015 |
| The helicase-like transcription factor redirects the autophagic flux and restricts human T cell leukemia virus type 1 infection A Beauvois, H Gazon, PS Chauhan, M Jamakhani, JR Jacques, M Thiry, ... Proceedings of the National Academy of Sciences 120 (31), e2216127120, 2023 | 2 | 2023 |
| Resistin mediates the immunoediting activity exerted by primary human macrophages towards mesothelioma cells M Hamaidia, M Jamakhani, JR Jacques, A Fontaine, A Scherpereel, ... Cancer Research 83 (7_Supplement), 663-663, 2023 | 1 | 2023 |
| Excess of blood eosinophils prior to therapy correlates with worse prognosis in mesothelioma M Willems, A Scherpereel, E Wasielewski, J Raskin, H Brossel, ... Frontiers in Immunology 14, 1148798, 2023 | 1 | 2023 |
| HDAC inhibition with valproate improves direct cytotoxicity of monocytes against mesothelioma tumor cells C Hoyos, A Fontaine, JR Jacques, V Heinen, R Louis, B Duysinx, ... Cancers 14 (9), 2164, 2022 | 1 | 2022 |
| Interactome and structural basis for targeting the human T-cell leukemia virus Tax oncoprotein SB Maseko, I Van Molle, K Blibek, C Gorgulla, J Olivet, J Blavier, ... bioRxiv, 2021.08. 25.457680, 2021 | 1 | 2021 |
